Abstract
Adenine base editors (ABEs) composed of an engineered adenine deaminase and the Streptococcus pyogenes Cas9 nickase enable adenine-to-guanine (A-to-G) single-nucleotide substitutions in a guide RNA (gRNA)-dependent manner. Here we demonstrate application of this technology in mouse embryos and adult mice. We also show that long gRNAs enable adenine editing at positions one or two bases upstream of the window that is accessible with standard single guide RNAs (sgRNAs). We introduced the Himalayan point mutation in the Tyr gene by microinjecting ABE mRNA and an extended gRNA into mouse embryos, obtaining Tyr mutant mice with an albino phenotype. Furthermore, we delivered the split ABE gene, using trans-splicing adeno-associated viral vectors, to muscle cells in a mouse model of Duchenne muscular dystrophy to correct a nonsense mutation in the Dmd gene, demonstrating the therapeutic potential of base editing in adult animals.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Komor, A.C., Kim, Y.B., Packer, M.S., Zuris, J.A. & Liu, D.R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).
Nishida, K. et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science 353, 1248–1257 (2016).
Gaudelli, N.M. et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).
Li, J., Sun, Y., Du, J., Zhao, Y. & Xia, L. Generation of targeted point mutations in rice by a modified CRISPR/Cas9 System. Mol. Plant 10, 526–529 (2017).
Kim, K. et al. Highly efficient RNA-guided base editing in mouse embryos. Nat. Biotechnol. 35, 435–437 (2017).
Kim, Y.B. et al. Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat. Biotechnol. 35, 371–376 (2017).
Banno, S., Nishida, K., Arazoe, T., Mitsunobu, H. & Kondo, A. Deaminase-mediated multiplex genome editing in Escherichia coli. Nat. Microbiol. 3, 423–429 (2018).
Kim, D. et al. Genome-wide target specificities of CRISPR RNA-guided programmable deaminases. Nat. Biotechnol. 35, 475–480 (2017).
Hu, J.H. et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556, 57–63 (2018).
Green, M.C. J. Hered. 52, 73–75 (1961).
Kwon, B.S., Halaban, R. & Chintamaneni, C. Molecular basis of mouse Himalayan mutation. Biochem. Biophys. Res. Commun. 161, 252–260 (1989).
Bae, S., Park, J. & Kim, J.S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473–1475 (2014).
Lai, Y. et al. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat. Biotechnol. 23, 1435–1439 (2005).
Sun, L., Li, J. & Xiao, X. Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. 6, 599–602 (2000).
Long, C. et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351, 400–403 (2016).
Nelson, C.E. et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351, 403–407 (2016).
Tabebordbar, M. et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351, 407–411 (2016).
van Putten, M. et al. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice. FASEB J. 27, 2484–2495 (2013).
Li, D., Yue, Y. & Duan, D. Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice. PLoS One 5, e15286 (2010).
Hur, J.K. et al. Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins. Nat. Biotechnol. 34, 807–808 (2016).
Sung, Y.H. et al. Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome Res. 24, 125–131 (2014).
Acknowledgements
This work was supported by the Institute for Basic Science (IBS-R021-D1 to J.-S.K).
Author information
Authors and Affiliations
Contributions
S.-M.R., T.K., K.K., K.L., and J.-S.K. designed the research. S.-M.R., T.K., K.K., K.L., G.B., S.-T.K., H.S.K., D.K., H.L., and E.C. performed the experiments. J.-S.K. supervised the research. All authors discussed the results and commented on the manuscript.
Corresponding author
Ethics declarations
Competing interests
J.-S.K. and T.K. have filed a patent application based on this work. J.-S.K. is a co-founder of and holds stock in ToolGen, Inc.
Integrated supplementary information
Supplementary Figure 1 Activities of ABEs using extended sgRNAs in HEK293T cells.
Base editing efficiencies of ABEs with extended sgRNAs at Site 18 (a), Site 19 (b), the HBB-E2 site (c), and the HBB-E3 site (d). (Left Y axis) Grey or black bars indicate the percentage of alleles that have a base-substitution mutation at the target adenine within two windows [positions 1-30 or 18-30 (upstream from PAM)], respectively. (Right Y axis) Blue dots indicate the relative base editing ratio, which was calculated by dividing the substitution allele frequency within the window of positions 18-30 by that within the window of positions 1-30. The PAM is shown in blue. Data are presented as mean ± s.e.m. (n = 3 biologically independent samples).
Supplementary Figure 2 Adenine editing efficiencies in mouse embryos.
(a) The target sequence at the Tyrosinase (Tyr) locus. The PAM sequence is shown in blue. The sgRNA target sequence is underlined. The targeted adenine in the wild-type sequence and the expected change in the sequence are shown in green and red, respectively. (b) Point mutation efficiencies associated with sgRNAs of different lengths (gX19, GX20, and GX21). Data are presented as mean ± s.e.m. (n = 8, 16 and 12 blastocysts, respectively). (c) Frequencies of blastocysts that carry the H420R mutation (Himalayan allele). (d) Alignments of mutant sequences from blastocysts after microinjection of ABE mRNA and Tyr-targeting sgRNAs of different lengths. The PAM and substitutions are shown in blue and red, respectively. The numbers in the column on the right indicate the frequency of each allele. WT, wild-type. H420R mutant allele frequencies are shown in red.
Supplementary Figure 3 Tyr mutations in newborn pups.
Alignments of mutant sequences from newborn pups. The altered nucleotides and the PAM site are shown in red and blue, respectively. The targeted position is shown in green.
Supplementary Figure 4 Germline transmission of Tyr mutant alleles.
Germline transmission of mutant alleles to F1 pups (101, 201-206, and 301-303) from F0 Tyr mutant mice (Tyr #1, Tyr #2 and Tyr #3) was confirmed using targeted deep sequencing. The PAM site and altered nucleotides are shown in blue and red, respectively. The column on the right indicates frequencies of mutant alleles.
Supplementary Figure 5 No off-target mutations at candidate sites in Tyr mutant mice.
Potential off-target sites with up to 3 mismatches, relative to the wild-type sequence, were identified using Cas-OFFinder. Substitution frequencies at these potential off-target sites were measured using targeted deep sequencing. PAM sequences and mismatched nucleotides are shown in blue and red, respectively. Data are presented as mean ± s.e.m. (n = 9 animals).
Supplementary Figure 6 Whole genome sequencing to assess off-target effects in the Tyr mutant mouse.
Genomes from the Tyr mutant mouse (Tyr #4) and a wild-type (WT) control mouse were sequenced using Illumina HiSeq X10. We identified unique single nucleotide variants (SNVs) in Tyr #4 by trimming out those in the WT control using the program 'Strelka' with the default 'eland' option. None of these SNVs other than the variations at the on-target site were found at potential off-target sites, identified using Cas-OFFinder, with up to 7 mismatches (207,848 sites) or with up to 5 mismatches and a DNA or RNA bulge (1,030,669 sites).
Supplementary Figure 7 Schematic diagram of trans-splicing AAV vector encoding ABE.
The first vector carries a U6 promoter driven sgRNA, Spc512 promoter, ecTadA fused to 5′- end of nCas9-NT cDNA, splice donor signal at the 3′ -end of nCas9-NT cDNA. The second vector contains nCas9-CT flanked by splice acceptor at the 5′ -end of nCas9-CT, followed by NLS, HA tag, and the bGH poly A signal. (a) The two split AAV-ABE vectors are coinfected into the target cells. (b) The two viral vectors are rejoined at the ITRs by recombination and led to heterodimer formation. (c) Target specific sgRNA and Pre-mRNA of ABE are made. (d) The intron along with the ITR by splicing is removed and ABE protein is made. SD, splicing donor; SA, splicing acceptor; NLS, nuclear localization signal; ITR, inverted terminal repeat.
Supplementary Figure 8 Base editing specificity of ABE in Dmd knockout mice.
Base editing frequencies at potential off-target sites identified by Cas-OFFinder were measured using targeted deep sequencing of genomic DNA isolated from muscles 8 weeks after injection of tsAAV: ABE. Mismatched nucleotides and the PAM sequence are shown in red and blue, respectively. OT; off-target site. Data are presented as mean ± s.e.m. (n = 3 animals).
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8 (PDF 3889 kb)
Supplementary Tables
Supplementary Tables 1–7 (PDF 156 kb)
Rights and permissions
About this article
Cite this article
Ryu, SM., Koo, T., Kim, K. et al. Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat Biotechnol 36, 536–539 (2018). https://doi.org/10.1038/nbt.4148
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.4148
This article is cited by
-
CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy
Translational Neurodegeneration (2024)
-
Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model
Nature Communications (2024)
-
A base editor for the long-term restoration of auditory function in mice with recessive profound deafness
Nature Biomedical Engineering (2024)
-
CRISPR technologies for genome, epigenome and transcriptome editing
Nature Reviews Molecular Cell Biology (2024)
-
Efficient prime editing in two-cell mouse embryos using PEmbryo
Nature Biotechnology (2024)